Sangamo Therapeutics, Inc.SGMONASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 118 | 111↓6.3% | 111↑0.5% | 176↑58.3% | 58↓67.2% |
| Gross Profit | -62 | 111↑277.2% | 99↓10.4% | 176↑77.7% | 58↓67.2% |
| Operating Income | -130 | -183↓41.5% | -201↓9.8% | -274↓36.1% | -104↑62.1% |
| Net Income | -121 | -178↓47.3% | -192↓7.8% | -258↓34.1% | -98↑62.0% |
| EBITDA | -124 | -166↓33.8% | -189↓14.2% | -97↑48.8% | -89↑8.0% |
| EPS Diluted | -0.90 | -1.23↓36.7% | -1.25↓1.6% | -1.48↓18.4% | -0.49↑66.9% |